Across the U.S., nearly 700 rural hospitals are at risk of closure. When they shut down, the impacts cascade: broken continuity, delayed care, and increased cyber risk in every new system a patient must navigate. The post The Hidden Fallout of Rural Hospital Closures: Patient Care Suffers – and So Does Data Security appeared first…
MIAMI — GOP lawmakers in the 10 states that refused the Affordable Care Act’s Medicaid expansion for over a decade have argued their conservative approach to growing government programs would pay off in the long run. Instead, the Republican-passed budget law that includes many of President Donald Trump’s priorities will pose at least as big…
By MIKE MAGEE What are the chances that citizens of New York, the largest city in the nation, would vote in a majority to oppose a formerly corrupt politician with a party machine behind him, and instead favor a little known candidate – the son of immigrant parents with “swarthy skin and belligerent independence,” from…
In 40 percent of attacks, threat actors threatened to physically harm executives at organizations that declined to pay a ransom demand, study states
A judge recently blocked an Arkansas law that would have banned PBMs from owning and operating pharmacies in the state. Although the state plans to appeal, one expert says the law likely has no future. The post Will the Arkansas PBM Law Survive A Judge’s Rejection? appeared first on MedCity News.
NIH documents viewed by KFF Health News show a pronounced decline in patients at the 200-bed NIH hospital from February through April
Jazz Pharmaceuticals’ dordaviprone, brand name Modeyso, is now the first FDA-approved therapy for recurrent H3 K27M-mutant diffuse midline glioma. The drug came from Jazz’s $935 million acquisition of Chimerix earlier this year. The post Rare and Aggressive Brain Cancer Affecting Children Gets Its First FDA-Approved Drug appeared first on MedCity News.
This brief examines state consent requirements for minors accessing contraceptive and abortion care, processes for minors to attempt to obtain abortion without parental involvement, and trends in state policy increasing requirements for parental involvement in minors’ health care decisions.
The move will save the behavioral healthcare company about $100 million over the next few years.
Q&A with Alan Weiss, M.D., M.B.A., Banner Health’s senior vice president of clinical advancement